| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 08/15/2002 | WO2001072685B1 Polyamine analogues as cytotoxic agents |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020111273 Insecticides, fungicides, miticides, plant safening agents |
| 08/15/2002 | CA2437392A1 Preparation of n-methylparoxetine and related intermediate compounds |
| 08/15/2002 | CA2436432A1 Colouring agents for keratin fibers containing (1,1'-biphenyl)-2,4-diamine derivatives in addition to novel (1,1'-biphenyl)-2,4-diamine-derivatives |
| 08/14/2002 | EP0986541A4 Process for covalently coupling organic compounds utilizing diboron derivatives |
| 08/14/2002 | EP0882703B1 Cyclic amic acid derivatives |
| 08/14/2002 | EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/14/2002 | EP0708761B1 Enhanced relaxivity monomeric and multimeric compounds |
| 08/14/2002 | CN1364162A Alpha-phenyl-beta-ketosulfone |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364153A Substituted phenoxyacetic acids |
| 08/13/2002 | US6433189 Tricyclic and tetracyclic taxane intermediates |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432656 Detection of calcilytic compound for calcium receptor bearing cell |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | US20020107408 Methods for the synthesis of dioxoalkanoic acid compounds |
| 08/08/2002 | US20020107407 Reacting monohaloethylene carbonate with dehydrohalogenating agent (triethyleneamine) in presence of ethylene carbonate |
| 08/08/2002 | US20020107406 Calcium receptor-active compounds |
| 08/08/2002 | DE10105313A1 Verfahren zur Herstellung von Verbindungen mit einer CF20-Brücke Process for the preparation of compounds having a bridge-CF20 |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/07/2002 | EP1229031A1 Process for the preparation of 3,4-methylenedioxy-mandelic acid |
| 08/07/2002 | EP1229012A1 Process for preparing beta-ketoester acetal |
| 08/07/2002 | EP1229010A1 Novel diarylamide derivatives and use thereof as medicines |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227722A1 Novel succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/01/2002 | WO2002059132A1 Intermediate compounds useful for making antiviral compounds |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059074A1 Benzylamine analogue |
| 08/01/2002 | WO2002012190A3 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 08/01/2002 | US20020103380 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 08/01/2002 | US20020103256 Contacting helminth, nematode, insect or acarid pests or parasites or their food supply, habitat or breeding grounds with a nitroethyl derivative |
| 08/01/2002 | US20020103239 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |
| 08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 08/01/2002 | US20020103205 Muscarinic antagonists |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | CA2435883A1 Benzylamine analogue |
| 08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 07/31/2002 | EP1226108A1 Diaryl-enynes |
| 07/31/2002 | EP1226107A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | CN1361765A Inhibitors of aspartyl protease |
| 07/31/2002 | CN1360890A Use of active retiene derivative with negative hormone and/or antagonist |
| 07/30/2002 | US6426364 Nervous system or psychological disorders |
| 07/30/2002 | US6426347 1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands |
| 07/25/2002 | WO2002057260A1 Compounds for use in the treatment of skin conditions |
| 07/25/2002 | WO2002057227A2 Process of enantiomerically enriched flavor and fragrance components |
| 07/25/2002 | WO2002057215A2 Sodium channel modulators |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |
| 07/25/2002 | US20020099220 Calcilytic compounds |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | US20020099050 E.g., 1-(1,4-benzodioxan-5-ylcarbonyl)-1,2,3,6-tetrahydro-pyridine), 1-(1,3-benzodioxol-5-ylcarbonyl)-piperidine); and 1-(1,3-benzodioxol-5-ylcarbonyl)-1,2,3,6-tetrahydropyridine |
| 07/25/2002 | US20020099038 O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 07/25/2002 | DE10158803A1 Production of difluoromethoxy-bridged compounds, involves addition of acid to ketene dithioketal, reaction of the carbenium salt with hydroxy compound and fluorodesulfurisation of the dithio-ortho-ester |
| 07/24/2002 | EP1225175A1 Synthesis of D-chiro-3-inosose and (+)-D-chiro-inositol |
| 07/24/2002 | EP1225172A1 Polyorthoester and curable composition containing the same |
| 07/24/2002 | EP1102743B1 Amide derivatives which are useful as cytokine inhibitors |
| 07/24/2002 | CN1360588A Hemisynthetic method and intermediate thereof |
| 07/24/2002 | CN1360570A Phenyl sulfamate derivs. |
| 07/24/2002 | CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates |
| 07/23/2002 | US6423752 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilizing and/or anti-inflammatory activity |
| 07/18/2002 | WO2002055513A1 Process for producing cyclic formal |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2001072685A3 Polyamine analogues as cytotoxic agents |
| 07/18/2002 | US20020095061 Enantioselectivity; epoxidizing and hydrolyzing the geranyloxy compound |
| 07/17/2002 | EP1222165A2 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 07/17/2002 | CN1358717A Optics decomposing method for coumarin dimer |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420423 Pesticides |
| 07/16/2002 | US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds |
| 07/16/2002 | US6420169 Device for generating preferential nucleotide sequences; for use as tools drug design |
| 07/11/2002 | WO2002053552A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both |
| 07/11/2002 | WO2002053522A2 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | WO2002053518A2 HALOGENATED-α,β-UNSATURATED-β-(SUBSTITUTED-AMINO) CARBOXYLATE ESTERS |
| 07/11/2002 | WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 07/11/2002 | US20020091242 Acid-sensitive compounds, their preparation and uses |
| 07/11/2002 | US20020090383 Phosphatidyl oligoglycerols |
| 07/11/2002 | CA2433828A1 Novel estrogen receptor ligands and methods i |
| 07/11/2002 | CA2433578A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP0784617B1 Substituted diphenyl oxazolines |
| 07/10/2002 | CN1358337A New electrolytes and lithium ion battery using the same |
| 07/10/2002 | CN1358169A N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 07/10/2002 | CN1087294C Novel compounds |
| 07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 07/09/2002 | US6416952 Photolithographic and other means for manufacturing arrays |
| 07/04/2002 | WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors |
| 07/04/2002 | WO2002051781A1 Process for producing optically active halohydrin compound |
| 07/04/2002 | US20020087011 Improved process and novel intermediates to endothelin receptor antagonists |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |